Pathogen recognition receptors, cancer and inflammation in the gut.
about
Function and regulation of retinoic acid-inducible gene-IGoblet cells and mucins: role in innate defense in enteric infectionsMucins and toll-like receptors: kith and kin in infection and cancerCurating the innate immunity interactome.The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer.Interferon regulatory factor 6 differentially regulates Toll-like receptor 2-dependent chemokine gene expression in epithelial cells.Intestinal goblet cells and mucins in health and disease: recent insights and progress.Treat your bug rightTumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.LBP and CD14 polymorphisms correlate with increased colorectal carcinoma risk in Han Chinese.Effect of Helicobacter pylori eradication on TLR2 and TLR4 expression in patients with gastric lesions.Toll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel diseaseCoexpression Network Analysis of Benign and Malignant Phenotypes of SIV-Infected Sooty Mangabey and Rhesus Macaque.Portrait of an immunoregulatory BifidobacteriumMicrobial Translocation and B Cell Dysfunction in Human Immunodeficiency Virus Disease.Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancersInhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals.Microbiota and dietary interactions: an update to the hygiene hypothesis?Intestinal stem cell injury and protection during cancer therapyMucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis.Anti-inflammatory activities of Gouania leptostachya methanol extract and its constituent resveratrol.Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis.Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression.Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion.Helicobacter pylori induces increased expression of Toll-like receptors and decreased Toll-interacting protein in gastric mucosa that persists throughout gastric carcinogenesis.Novel Immunomodulatory Flagellin-Like Protein FlaC in Campylobacter jejuni and Other Campylobacterales.Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma.TLR Specific Immune Responses against Helminth Infections.Colorectal cancer prevention: Immune modulation taking the stage.The Pathologic Role of Toll-Like Receptor 4 in Prostate Cancer.AKT-targeted anti-inflammatory activity of calyx ethanolic extract
P2860
Q24632537-695FCF75-3952-4825-95B0-76A396B46EADQ26822449-3E896A5A-895C-412E-941F-B4BC4323E66AQ26830597-0AFE2394-8713-4536-B7CA-0C8AD598B257Q33667546-8C424CA7-22E5-4E04-9DF7-AF8B66304269Q33839949-E5240313-3CB1-441C-AB66-6857B45CCFA6Q33888640-E8C7BA94-0936-417F-AF59-952E7E8CBCB8Q34102377-FB752CCB-D59C-43C6-A3C6-C6193DC5D682Q34760291-461D7615-CBC2-497E-8662-37ABC47991D1Q34876594-465CC3A1-BB17-4F4F-8AAE-7CA665459420Q34993700-1E54E446-202C-49A8-B8C5-6AFB955B717CQ35271888-5C071602-ECBA-4E6A-8390-9AF01F31BFCFQ35420431-61B1BCC7-5FC7-4B2F-A3B2-42B72B6DFB9BQ36046669-85863E42-8E48-4FBC-93E7-1798A65B62F1Q36187698-97D5F104-DC66-4966-ABC5-2F0C94A66714Q37015889-22567DD5-F0DF-44D0-8ABC-CA2C1F5A3C90Q37291780-DBA0787D-F47F-42B3-99BE-35B206DDBBC2Q37438177-73ACE4BA-1769-4220-B130-41232B110E4EQ37976874-203A8B83-6D75-4D09-A031-0C8B60D3AAA6Q38200606-2919DFEC-715B-432E-B9A9-C7AEE2FEAD34Q38246766-4F581D84-4C55-410B-86A5-5AD34E947A4FQ38938710-EA8B78C6-2F28-4693-AB1F-2384293AFAE0Q38945757-F9005C5A-8984-41BE-8B92-58A6E5B91AF5Q39028490-1CF407E2-E95E-4493-AFE1-B597A7EF2043Q39108713-A9E517E3-9999-4A84-8158-68A9810F16FCQ39256403-EE34C3FF-DA7D-44E9-BF52-65EF35CD1625Q39537470-2CC94718-D215-4E46-BCD2-AD7E4D690E6CQ40700523-3CFF1A16-9BE7-4889-AE4D-51A42714AE18Q42493565-762569B4-A3C0-445D-814E-C250466EF492Q43915727-EB68FD33-1D0A-4EDD-9487-9A5AFB3B132CQ48145971-495A1CEE-8159-4078-AE7D-C8AA0796CA57Q49391998-221CCF34-FB5E-43E5-BE32-1F4FBB555530Q55339148-6D5026A1-AE02-43ED-A8FE-4F3146063836Q58595391-96A1C3BC-EE06-4B83-AFCE-6A037287EECE
P2860
Pathogen recognition receptors, cancer and inflammation in the gut.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pathogen recognition receptors, cancer and inflammation in the gut.
@ast
Pathogen recognition receptors, cancer and inflammation in the gut.
@en
type
label
Pathogen recognition receptors, cancer and inflammation in the gut.
@ast
Pathogen recognition receptors, cancer and inflammation in the gut.
@en
prefLabel
Pathogen recognition receptors, cancer and inflammation in the gut.
@ast
Pathogen recognition receptors, cancer and inflammation in the gut.
@en
P2860
P1476
Pathogen recognition receptors, cancer and inflammation in the gut
@en
P2093
Masayuki Fukata
P2860
P304
P356
10.1016/J.COPH.2009.09.006
P577
2009-10-12T00:00:00Z